Clinical Trials

Clinical Trials

 

 

  • APPRAISE-2

    Apixaban for Prevention of Acute Ischemic Events – 2: A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban in Subjects with a Recent Acute Coronary Syndrome

      To see more                                                                         

     


        Status: Finished


  • ARISTOTLE 



    A Phase 3, Active Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects with Nonvalvular Atrial Fibrillation

     

      To see more                                                                          

     


       

     Status: Finished

     

  • ATMOSPHERE




    A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV).


      

     Status: Finished

  • RECORD



    Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia Control in Diabetes.


       

    Status: Finished

     

  • TRACER

     

    Trial to Assess the Effects of SCH 530348 in Preventing Heart Attack and Stroke in Patients with Acute Coronary Syndrome.

     

      To see more                                                                          

     

       

    Status: Finished

     

  • BRIDGE ACS


    Brazilian Intervention to Improve the Evidence-based in Routine Practice – Acute Coronary Syndromes

    To see more                                                                          
            
     
     

      

     Status: Finished

     

  • EMANA

     

    Evaluation of the effect of long infrared radiation, emitted by compression stocking in the adjuvant treatment of Gynoid lipodystrophy (Cellulite) 

     

    Status: Finished

     

     

  • ISCHEMIA

     

    International Study of Comparative Health Effectiveness with Medical and Invasive Approaches


  •  

  • STICHES


    Surgical Treatment for Ischemic Heart Failure Trial.



    Status: Finished

     

  • TECOS

     

    A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control on Mono- or Dual Combination Oral Antihyperglycemic Therapy.

  •  

     

  • CABANA

     

    Catheter Ablation versus. Antiarrhythmic Drug Therapy for Atrial Fibrillation Trial.

     

    Status: Finished

     

  • CHAMPION PHOENIX 

     


    A Phase 3 Trial Comparing Cangrelor to Clopidogrel Standard of Care Therapy in Subjects who require Percutaneous Coronary Intervention.


       

    Status: Finished

     

  • LOAD

     

    A multicentre randomized controlled trial of statins attack dose for prevention of cardiovascular complications in high risk noncardiac surgeries.   

     

  • SECURE

     

    A randomized, multicentre clinical trial to assess the effect of atorvastatin in patients with acute coronary syndrome and intended percutaneous coronary intervention.   

                Interview - Dr Renato Delascio Lopes

     

  • CEFAZOLINA

     

    An Open Label Study to Describe the Pharmacokinetics of Cefazolin in Preterm Neonates

     

  • I RBH


     


    Brazilian Cardiovascular Record of Systemic Arterial Hypertension.


  • SMART-ACS

     

    A translational approach integrating specific population models of clinical risk, platelet reactivity, biomarkers and tissue metabolomics.

     Status: Finished

     

  • OLMESARTAN META-ANALYSIS

     

    The objective of this patient-level meta-analysis is to evaluate the cardiovascular risk and mortality risk in  olmesartan medoxomil-treated patients  compared to the risk in patients receiving either   placebo or active control drugs using randomized, double blind, controlled trials that meet criteria defined by the FDA.


    Status: Finished

     

  • ODYSSEY

     


    A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of  SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients who have Recently Experience an Acute Coronary Syndrome.